Impact of H1N1, H7N9, ASFV, dengue virus and COVID-19 on pharmaceutical manufacturing firms' R&D investments and economic consequences: Evidence from China

What drives innovation? Lessons from COVID-19 R&D

(2022) Ruchir Agarwal et al.   JOURNAL OF HEALTH ECONOMICS

Understanding Vaccine Safety and the Roles of the FDA and the CDC

(2022) H. Cody Meissner   NEW ENGLAND JOURNAL OF MEDICINE

Delivering Pandemic Vaccines in 100 Days — What Will It Take?

(2022) Melanie Saville et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fintech, financial constraints and innovation: Evidence from China

(2022) Na Ding et al.   JOURNAL OF CORPORATE FINANCE

Responding to epidemic-driven demand: the role of supply channels

(2022) Jaeseok Lee et al.   INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

(2021) Olivier J Wouters et al.   LANCET

Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development

(2021) Nicole Lurie et al.   LANCET

What are the obligations of pharmaceutical companies in a global health emergency?

(2021) Ezekiel J Emanuel et al.   LANCET

Learning from crisis: building resilient systems to combat future pandemics

(2021) Ilona Kickbusch et al.   LANCET

African swine fever virus vaccine candidate ASFV‐G‐ Δ I177L efficiently protects European and native pig breeds against circulating Vietnamese field strain

(2021) Xuan Hanh Tran et al.   Transboundary and Emerging Diseases

Economic impacts of Wuhan 2019‐nCoV on China and the world

(2020) Foster K. Ayittey et al.   JOURNAL OF MEDICAL VIROLOGY

Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study

(2020) Juanjuan Zhang et al.   LANCET INFECTIOUS DISEASES

Rapid COVID-19 vaccine development

(2020) Barney S. Graham   SCIENCE

Short and long term impacts of COVID-19 on the pharmaceutical sector

(2020) Nayyereh Ayati et al.   DARU-Journal of Pharmaceutical Sciences

Pandemic risk: how large are the expected losses?

(2018) Victoria Y Fan et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

(2017) Kapil Bahl et al.   MOLECULAR THERAPY

Advances in the development of influenza virus vaccines

(2015) Florian Krammer et al.   NATURE REVIEWS DRUG DISCOVERY

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

(2012) Fatimah S Dawood et al.   LANCET INFECTIOUS DISEASES